Determination |
Normal Reference Value |
|||||||||||||||||||||||||||||||
Conventional units |
SI units |
|||||||||||||||||||||||||||||||
Blood, Plasma or Serum | ||||||||||||||||||||||||||||||||
Ammonia (NH3) – diffusion | 20-120 mcg/dl | 12-70 mcmol/L | ||||||||||||||||||||||||||||||
Ammonia Nitrogen | 15-45 µg/dl | 11-32 µmol/L | ||||||||||||||||||||||||||||||
Amylase | 35-118 IU/L | 0.58-1.97 mckat/L | ||||||||||||||||||||||||||||||
Anion gap (Na+-[Cl – + HCO3– ]) (P) | 7-16 mEq/L | 7-16 mmol/L | ||||||||||||||||||||||||||||||
Antithrombin III (AT III) | 80–120 U/dl | 800–1200 U/L | ||||||||||||||||||||||||||||||
Bicarbonate | ||||||||||||||||||||||||||||||||
Arterial | 21–28 mEq/L | 21–28 mmol/L | ||||||||||||||||||||||||||||||
Venous | 22–29 mEq/L | 22–29 mmol/L | ||||||||||||||||||||||||||||||
Bilirubin | ||||||||||||||||||||||||||||||||
Conjugated (direct) Total | £ 0.2 mg/dl & 0.1–1 mg/dl |
£ 4 mcmol/L & 2–18 mcmol/L |
||||||||||||||||||||||||||||||
Calcitonin | < 100 pg/ml | < 100 ng/L | ||||||||||||||||||||||||||||||
Calcium | ||||||||||||||||||||||||||||||||
Total | 8.6–10.3 mg/dl | 2.2–2.74 mmol/L | ||||||||||||||||||||||||||||||
Ionized | 4.4–5.1 mg/dl | 1–1.3 mmol/L | ||||||||||||||||||||||||||||||
Carbon dioxide content (plasma) | 21–32 mmol/L | 21–32 mmol/L | ||||||||||||||||||||||||||||||
Carcinoembryonic antigen | < 3 ng/ml | < 3 mcg/L | ||||||||||||||||||||||||||||||
Chloride | 95–110 mEq/L | 95–110 mmol/L | ||||||||||||||||||||||||||||||
Coagulation screen | ||||||||||||||||||||||||||||||||
Bleeding time | 3–9.5 min | 180–570 sec | ||||||||||||||||||||||||||||||
Prothrombin time | 10–13 sec | 10–13 sec | ||||||||||||||||||||||||||||||
Partial thromboplastin time (activated) | 22–37 sec | 22–37 sec | ||||||||||||||||||||||||||||||
Protein C | 0.7–1.4 µ/ml | 700–1400 U/ml | ||||||||||||||||||||||||||||||
Protein S | 0.7–1.4 µ/ml | 700–1400 U/ml | ||||||||||||||||||||||||||||||
Copper, total | 70–160 mcg/dl | 11–25 mcmol/L | ||||||||||||||||||||||||||||||
Corticotropin (ACTH adrenocorticotropic hormone) – 0800 hr | < 60 pg/ml | < 13.2 pmol/L | ||||||||||||||||||||||||||||||
Cortisol | ||||||||||||||||||||||||||||||||
0800 hr | 5–30 mcg/dl | 138–810 nmol/L | ||||||||||||||||||||||||||||||
1800 hr | 2–15 mcg/dl | 50–410 nmol/L | ||||||||||||||||||||||||||||||
2000 hr | £ 50% of 0800 hr | £ 50% of 0800 hr | ||||||||||||||||||||||||||||||
Creatine kinase | ||||||||||||||||||||||||||||||||
Female | 20–170 IU/L | 0.33–2.83 mckat/L | ||||||||||||||||||||||||||||||
Male | 30–220 IU/L | 0.5–3.67 mckat/L | ||||||||||||||||||||||||||||||
Creatinine kinase isoenzymes, MB fraction | 0–12 IU/L | 0–0.2 mckat/L | ||||||||||||||||||||||||||||||
Creatinine | 0.5–1.7 mg/dl | 44–150 mcmol/L | ||||||||||||||||||||||||||||||
Fibrinogen (coagulation factor I) | 150–360 mg/dl | 1.5–3.6 g/L | ||||||||||||||||||||||||||||||
Follicle-stimulating hormone (FSH) | ||||||||||||||||||||||||||||||||
Female | 2–13 mlU/ml | 2–13 IU/L | ||||||||||||||||||||||||||||||
Midcycle | 5–22 mlU/ml | 5–22 IU/L | ||||||||||||||||||||||||||||||
Male | 1–8 mlU/ml | 1–8 IU/L | ||||||||||||||||||||||||||||||
Glucose, fasting | 65–115 mg/dl | 3.6–6.3 mmol/L | ||||||||||||||||||||||||||||||
Glucose Tolerance Test (Oral) | ||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||
(g) – Glutamyltransferase (GGT) | ||||||||||||||||||||||||||||||||
Male | 9–50 units/L | 9–50 units/L | ||||||||||||||||||||||||||||||
Female | 8–40 units/L | 8–40 units/L | ||||||||||||||||||||||||||||||
Haptoglobin | 44–303 mg/dl | 0.44–3.03 g/L | ||||||||||||||||||||||||||||||
Hematologic Tests | ||||||||||||||||||||||||||||||||
Fibrinogen | 200–400 mg/dl | 2–4 g/L | ||||||||||||||||||||||||||||||
Hematocrit (Hct) | ||||||||||||||||||||||||||||||||
female | 36%-44.6% | 0.36–0.446 fraction of 1 | ||||||||||||||||||||||||||||||
male | 40.7%-50.3% | 0.4–0.503 fraction of 1 | ||||||||||||||||||||||||||||||
Hemoglobin A 1C | 5.3%-7.5% of total Hgb | 0.053–0.075 | ||||||||||||||||||||||||||||||
Hemoglobin (Hb) | ||||||||||||||||||||||||||||||||
female | 12.1–15.3 g/dl | 121–153 g/L | ||||||||||||||||||||||||||||||
male | 13.8–17.5 g/dl | 138–175 g/L | ||||||||||||||||||||||||||||||
Leukocyte count (WBC) | 3800–9800/mcl | 3.8–9.8 x 109/L | ||||||||||||||||||||||||||||||
Erythrocyte count (RBC) | ||||||||||||||||||||||||||||||||
female | 3.5–5 x 106/mcl | 3.5–5 x 1012/L | ||||||||||||||||||||||||||||||
male | 4.3–5.9 x 106/mcl | 4.3–5.9 x 1012/L | ||||||||||||||||||||||||||||||
Mean corpuscular volume (MCV) | 80–97.6 mcm3 | 80–97.6 fl | ||||||||||||||||||||||||||||||
Mean corpuscular hemoglobin (MCH) | 27–33 pg/cell | 1.66–2.09 fmol/cell | ||||||||||||||||||||||||||||||
Mean corpuscular hemoglobin concentrate (MCHC) | 33–36 g/dl | 20.3–22 mmol/L | ||||||||||||||||||||||||||||||
Erythrocyte sedimentation rate (sedrate, ESR) | £30 mm/hr | £30 mm/hr | ||||||||||||||||||||||||||||||
Erythrocyte enzymes | ||||||||||||||||||||||||||||||||
Glucose-6 – Pphosphate dehydrognase (G-6-PD) | 250–5000 units/106 cells | 250–5000 mcunits/cell |
Determination |
Reference Value |
|||||||||||||||||||||||||
(Conventional units) | (SI units) | |||||||||||||||||||||||||
Blood, Plasma or Serum:
Ammonia (NH3) – diffusion |
20–120 mcg/dl | 12–70 mcmol/L | ||||||||||||||||||||||||
Ammonia Nitrogen | 15–45 µg/dl | 11–32 µmol/L | ||||||||||||||||||||||||
Amylase | 35–118 IU/L | 0.58–1.97 mckat/L | ||||||||||||||||||||||||
Anion gap (Na+-[Cl – + HCO3–]) (P) | 7–16 mEq/L | 7–16 mmol/L | ||||||||||||||||||||||||
Antithrombin III (AT III) | 80–120 U/dl | 800–1200 U/L | ||||||||||||||||||||||||
|
21–28 mEq/L 22–29 mEq/L |
21–28 mmol/L
22–29 mmol/L |
||||||||||||||||||||||||
Bilirubin: Conjugated (direct) Total | £ 0.2 mg/dl (0.1–1 mg/dl) |
£ 4 mcmol/L (2–18 mcmol/L) |
||||||||||||||||||||||||
Calcitonin | < 100 pg/ml | < 100 ng/L | ||||||||||||||||||||||||
|
8.6–10.3 mg/dl
4.4–5.1 mg/dl |
2.2–2.74 mmol/L
1–1.3 mmol/L |
||||||||||||||||||||||||
Carbon dioxide content (plasma) | 21–32 mmol/L | 21–32 mmol/L | ||||||||||||||||||||||||
Carcinoembryonic antigen | < 3 ng/ml | < 3 mcg/L | ||||||||||||||||||||||||
Chloride | 95–110 mEq/L | 95–110 mmol/L | ||||||||||||||||||||||||
Coagulation screen:
Bleeding time Partial thromboplastin time (activated) Protein C Protein S |
3–9.5 min
10–13 sec 22–37 sec 0.7–1.4 µ/ml 0.7–1.4 µ/ml |
180–570 sec
10–13 sec 22–37 sec 700–1400 U/ml 700–1400 U/ml |
||||||||||||||||||||||||
Copper, total | 70–160 mcg/dl | 11–25 mcmol/L | ||||||||||||||||||||||||
Corticotropin (ACTH adrenocorticotropic hormone) – 0800 hr |
< 60 pg/ml | < 13.2 pmol/L | ||||||||||||||||||||||||
|
5–30 mcg/dl 2–15 mcg/dl £ 50% of 0800 hr |
138–810 nmol/L
50–410 nmol/L £ 50% of 0800 hr |
||||||||||||||||||||||||
|
20–170 IU/L
30–220 IU/L |
0.33–2.83 mckat/L 0.5–3.67 mckat/L |
||||||||||||||||||||||||
Creatinine kinase isoenzymes, MB fraction | 0–12 IU/L | 0–0.2 mckat/L | ||||||||||||||||||||||||
Creatinine | 0.5–1.7 mg/dl | 44–150 mcmol/L | ||||||||||||||||||||||||
Fibrinogen (coagulation factor I) | 150–360 mg/dl | 1.5–3.6 g/L | ||||||||||||||||||||||||
Follicle-stimulating hormone (FSH):
Female Midcycle Male |
2–13 mlU/ml
5–22 mlU/ml |
2–13 IU/L
5–22 IU/L 1–8 IU/L |
||||||||||||||||||||||||
Glucose, fasting | 65–115 mg/dl | 3.6–6.3 mmol/L | ||||||||||||||||||||||||
Glucose Tolerance Test (Oral)
Fasting 60 min 120 min |
|
|
||||||||||||||||||||||||
(g) -Glutamyltransferase (GGT):
Male Female |
9–50 units/L 8–40 units/L |
9–50 units/L
8–40 units/L |
||||||||||||||||||||||||
Haptoglobin | 44–303 mg/dl | 0.44–3.03 g/L | ||||||||||||||||||||||||
Determination |
Reference Value |
|||||||||||||||||||||||||
Conventional units | SI units | |||||||||||||||||||||||||
Hematologic tests:
Fibrinogen Hematocrit (Hct), male Hemoglobin A 1C Hemoglobin (Hb), male Leukocyte count (WBC) male Mean corpuscular volume (MCV) Mean corpuscular hemoglobin Mean corpuscular hemoglobin concentrate (MCHC) Erythrocyte sedimentation rate (sedrate, ESR) |
200–400 mg/dl
36%-44.6% 40.7%-50.3% 5.3%-7.5% of total Hgb 12.1–15.3 g/dl 13.8–17.5 g/dl 3800–9800/mcl 3.5–5 x 106/mcl 4.3–5.9 x 106/mcl 80–97.6 mcm3 27–33 pg/cell 33–36 g/dl £30 mm/hr |
2–4 g/L
0.36–0.446 fraction of 1 0.4–0.503 fraction of 1 0.053–0.075 121–153 g/L 138–175 g/L 3.8–9.8 x 109/L 3.5–5 x 1012/L 4.3–5.9 x 1012/L 80–97.6 fl 1.66–2.09 fmol/cell 20.3–22 mmol/L £ 30 mm/hr |
||||||||||||||||||||||||
Erythrocyte enzymes:
Glucose-6 – (G-6-PD) Ferritin Folic acid: normal Platelet count Reticulocytes Vitamin B12 |
250–5000 units/106 cells
10–383 ng/ml >3.1–12.4 ng/ml 150–450 x 103/mcl 0.5%-1.5% of erythrocytes 223–1132 pg/ml |
250–5000 mcunits/cell
23–862 pmol/L 7–28.1 nmol/L 150–450 x 109/L 0.005–0.015 165–835 pmol/L |
||||||||||||||||||||||||
|
30–160 mcg/dl
45–160 mcg/dl |
5.4–31.3 mcmol/L
8.1–31.3 mcmol/L |
||||||||||||||||||||||||
Iron binding capacity | 220–420 mcg/dl | 39.4–75.2 mcmol/L | ||||||||||||||||||||||||
Isocitrate dehydrogenase | 1.2–7 units/L | 1.2–7 units/L | ||||||||||||||||||||||||
Isoenzymes
Fraction 1 Fraction 2 Fraction 3 Fraction 4 Fraction 5 |
14%-26% of total
29%-39% of total 20%-26% of total 8%-16% of total 6%-16% of total |
0.14–0.26 fraction of total
0.29–0.39 fraction of total 0.08–0.16 fraction of total 0.06–0.16 fraction of total |
||||||||||||||||||||||||
Lactate dehydrogenase | 100–250 IU/L | 1.67–4.17 mckat/L | ||||||||||||||||||||||||
Lactic acid (lactate) | 6–19 mg/dl | 0.7–2.1 mmol/L | ||||||||||||||||||||||||
Lead | £ 50 mcg/dl | £ 2.41 mcmol/L | ||||||||||||||||||||||||
Lipase | 10–150 units/L | 10–150 units/L | ||||||||||||||||||||||||
Lipids:
Total Cholesterol Desirable Borderline-high High LDL Desirable Borderline-high High HDL (low) Triglycerides Desirable Borderline-high High Very high |
< 200 mg/dl
200–239 mg/dl > 239 mg/dl < 130 mg/dl 130–159 mg/dl > 159 mg/dl < 35 mg/dl < 200 mg/dl 200–400 mg/dl 400–1000 mg/dl > 1000 mg/dl |
< 5.2 mmol/L
< 5.2–6.2 mmol/L > 6.2 mmol/L < 3.36 mmol/L 3.36–4.11 mmol/L > 4.11 mmol/L < 0.91 mmol/L < 2.26 mmol/L 2.26–4.52 mmol/L 4.52–11.3 mmol/L > 11.3 mmol/L |
||||||||||||||||||||||||
Magnesium | 1.3–2.2 mEq/L | 0.65–1.1 mmol/L | ||||||||||||||||||||||||
Osmolality | 280–300 mOsm/kg | 280–300 mmol/kg | ||||||||||||||||||||||||
Oxygen saturation (arterial) | 94%-100% | 0.94 – fraction of 1 | ||||||||||||||||||||||||
PCO2, arterial | 35–45 mm Hg | 4.7–6 kPa | ||||||||||||||||||||||||
pH, arterial | 7.35–7.45 | 7.35–7.45 | ||||||||||||||||||||||||
Determination |
Reference Value |
|||||||||||||||||||||||||
Conventional units |
SI units |
|||||||||||||||||||||||||
PO, arterial: Breathing room air
On 100% O |
80–105 mm Hg
> 500 mm Hg |
10.6–14 kPa | ||||||||||||||||||||||||
Phosphatase (acid), total at 37°C | 0.13–0.63 IU/L | 2.2–10.5 IU/L or
2.2–10.5 mckat/L |
||||||||||||||||||||||||
Phosphatase alkaline | 20–130 IU/L | 20–130 IU/L or
0.33–2.17 mckat/L |
||||||||||||||||||||||||
Phosphorus, inorganic, (phosphate) | 2.5–5 mg/dl | 0.8–1.6 mmol/L | ||||||||||||||||||||||||
Potassium | 3.5–5 mEq/L | 3.5–5 mmol/L | ||||||||||||||||||||||||
Progesterone
Female Follicular phase Luteal phase Male |
0.1–1.5 ng/ml
0.1–1.5 ng/ml < 0.5 ng/ml |
0.32–4.8 nmol/L
0.32–4.8 nmol/L 8–89 nmol/L < 1.6 nmol/L |
||||||||||||||||||||||||
Prolactin | 1.4–24.2 ng/ml | 1.4–24.2 mcg/L | ||||||||||||||||||||||||
Prostate specific antigen
Protein: Total Globulin |
0–4 ng/ml
6–8 g/dl 3.6–5 g/dl 2.3–3.5 g/dl |
0–4 ng/ml 60–80 g/L 36–50 g/L 23–35 g/L |
||||||||||||||||||||||||
Rheumatoid factor | < 60 IU/ml | < 60 kIU/L | ||||||||||||||||||||||||
Sodium | 135–147 mEq/L | 135–147 mmol/L | ||||||||||||||||||||||||
Testosterone: Female Male |
6–86 ng/dl
270–1070 ng/dl |
0.21–3 nmol/L
9.3–37 nmol/L |
||||||||||||||||||||||||
Thyroid Hormone Function Tests:
Thyroid-stimulating hormone (TSH) Thyroxine-binding globulin capacity Total triiodothyronine (T3) Total thyroxine by RIA (T4) |
0.35–6.2 mcU/ml
10–26 mcg/dl 75–220 ng/dl 4–11 mcg/dl |
0.35–6.2 mU/L
100–260 mcg/L 1.2–3.4 nmol/L 51–142 nmol/L 0.25–0.38 fraction of 1 |
||||||||||||||||||||||||
Transaminase, AST (aspartate aminotransferase, SGOT) | 11–47 IU/L | 0.18–0.78 mckat/L | ||||||||||||||||||||||||
Transaminase, ALT (alanine aminotransferase, SGPT) | 7–53 IU/L | 0.12–0.88 mckat/L | ||||||||||||||||||||||||
Transferrin | 220–400 mg/dL | 2.20–4.00 g/L | ||||||||||||||||||||||||
Urea nitrogen (BUN) | 8–25 mg/dl | 2.9–8.9 mmol/L | ||||||||||||||||||||||||
Uric acid | 3–8 mg/dl | 179–476 mcmol/L | ||||||||||||||||||||||||
Vitamin A (retinol) | 15–60 mcg/dl | 0.52–2.09 mcmol/L | ||||||||||||||||||||||||
Zinc | 50–150 mcg/dl | 7.7–23 mcmol/L |
1 Tergantung pada usia
2 Bayi dan anak sampai 104 U/L
3 Bayi usia 1 tahun sampai 6 mg/dl
Urine |
||
Determination |
Reference Value |
|
Conventional units | SI units | |
Calcium | 50–250 mcg/day | 1.25–6.25 mmol/day |
Catecholamines:
Epinephrine Norepinephrine |
< 20 mcg/day
< 100 mcg/day |
< 109 nmol/day
< 590 nmol/day |
Catecholamines, 24-hr | < 110 µg | < 650 nmol |
Copper | 15–60 mcg/day | 0.24–0.95 mcmol/day |
Creatinine:
Child Adolescent Female |
8–22 mg/kg
8–30 mg/kg 0.6–1.5 g/day 0.8–1.8 g/day |
71–195 µmol/kg 71–265 µmol/kg 5.3–13.3 mmol/day 7.1–15.9 mmol/day |
pH | 4.5–8 | 4.5–8 |
Phosphate | 0.9–1.3 g/day | 29–42 mmol/day |
Potassium | 25–100 mEq/day | 25–100 mmol/day |
Protein
Total At rest |
1–14 mg/dL
50–80 mg/day |
10–140 mg/L
50–80 mg/day |
Protein, quantitative | < 150 mg/day | < 0.15 g/day |
Sodium | 100–250 mEq/day | 100–250 mmol/day |
Specific gravity, random | 1.002–1.030 | 1.002–1.030 |
Uric acid, 24-hr | 250–750 mg | 1.48–4.43 mmol |
1 Tergantung pada diet.
Drug Levels* |
|||
Drug Determination |
Reference Value |
||
Conventional units |
SI units |
||
Aminoglycosides | Amikacin
(trough) (peak) |
1–8 mcg/ml
1.7–13.7 mcmol/L |
20–30 mcg/ml 34–51 mcmol/L |
Gentamicin
(trough) (peak) |
0.5–2 mcg/ml
6–10 mcg/ml |
1–4.2 mcmol/L
12.5–20.9 mcmol/L |
|
Kanamycin
(trough) (peak) |
5–10 mcg/ml 20–25 mcg/ml |
nd
nd |
|
Netilimicin
(trough) (peak) |
0.5–2 mcg/ml 6–10 mcg/ml |
nd
nd |
|
Streptomycin
(trough) (peak) |
< 5 mcg/ml 5–20 mcg/ml |
nd
nd |
|
Tobramycin
(trough) (peak) |
0.5–2 mcg/ml 5–20 mcg/ml |
1.1–4.3 mcmol/L
12.8–21.8 mcmol/L |
|
Drug Determination |
Reference Value |
||
Conventional units |
SI units |
||
Antiarrhythmics | Amiodarone | 0.5–2.5 mcg/ml | 1.5–4 mcmol/L |
Bretylium | 0.5–1.5 mcg/ml | nd | |
Digitoxin | 9–25 mcg/L | 11.8–32.8 nmol/L | |
Digoxin | 0.8–2 ng/ml | 0.9–2.5 nmol/L | |
Disopyramide | 2–8 mcg/ml | 6–18 mcmol/L | |
Flecainide | 0.2–1 mcg/ml | nd | |
Lidocaine | 1.5–6 mcg/ml | 4.5–21.5 mcmol/L | |
Mexiletine | 0.5–2 mcg/ml | nd | |
Procainamide | 4–8 mcg/ml | 17–34 mcmol/ml | |
Propranolol | 50–200 ng/ml | 190–770 nmol/L | |
Quinidine | 2–6 mcg/ml | 4.6–9.2 mcmol/L | |
Tocainide | 4–10 mcg/ml | nd | |
Verapamil | 0.08–0.3 mcg/ml | nd | |
Anticonvulsants | Carbamazepine | 4–12 mcg/ml | 17–51 mcmol/L |
Phenobarbital | 10–40 mcg/ml | 43–172 mcmol/L | |
Phenytoin | 10–20 mcg/ml | 40–80 mcmol/L | |
Primidone | 4–12 mcg/ml | 18–55 mcmol/L | |
Valproic Acid | 40–100 mcg/ml | 280–700 mcmol/L | |
Antidepressants | Amitriptyline | 110–250 ng/ml | 500–900 nmol/L |
Amoxapine | 200–500 ng/ml | nd | |
Bupropion | 25–100 ng/ml | nd | |
Clomipramine | 80–100 ng/ml | nd | |
Desipramine | 115–300 ng/ml | nd | |
Doxepin | 110–250 ng/ml | nd | |
Imipramine | 225–350 ng/ml | nd | |
Maprotiline | 200–300 ng/ml | nd | |
Nortriptyline | 50–150 ng/ml | nd | |
Protriptyline | 70–250 ng/ml | nd | |
Trazodone | 800–1600 ng/ml | nd | |
Antipsychotics | Chlorpromazine | 50–300 ng/ml | 150–950 nmol/L |
Fluphenazine | 0.13–2.8 ng/ml | nd | |
Haloperidol | 5–20 ng/ml | nd | |
Perphenazine | 0.8–1.2 ng/ml | nd | |
Thiothixene | 2–57 ng/ml | nd | |
Drug Determination |
Reference Value |
||
Conventional units |
SI units |
||
Miscellaneous | Amantadine
Amrinone |
300 ng/ml
3.7 mcg/ml |
nd
nd |
Chloramphenicol | 10–20 mcg/ml | 31–62 mcmol/L | |
Cyclosporine | 250–800 ng/ml
(whole blood, RIA) |
nd
nd |
|
Ethanol | 0 mg/dl | 0 mmol/L | |
Hydralazine | 100 ng/ml | nd | |
Lithium | 0.6–1.2 mEq/L | 0.6–1.2 mmol/L | |
Salicylate | 100–300 mg/L | 724–2172 mcmol/L | |
Sulfonamide | 5–15 mg/dl | nd | |
Terbutaline | 0.5–4.1 ng/ml | nd | |
Theophylline | 10–20 mcg/ml | 55–110 mcmol/L | |
Vancomycin
(trough) (peak) |
5–15 ng/ml 20–40 mcg/ml |
nd
nd |
* Nilai yang diberikan secara umum dapat digunakan untuk terapi tanpa terjadi efek toksik pada kebanyakan pasien, Namun pengecualian juga tidak jarang terjadi.
1 nd = data tidak tersedia.
2 Metabolit N-desmethyl beserta turunannya.
3 Nilai 24 jam.
4 Toksik: 50–100 mg/dl (10.9–21.7 mmol/L).
Diambil dari The Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure, National Institutes of Health.
Classification of Blood Pressure * |
|||
Category |
Reference value |
||
Systolic (mm Hg) |
Diastolic (mm Hg) |
||
Optimal | < 120 | and | < 80 |
Normal | < 130 | and | < 85 |
High-normal | 130–139 | or | 85–89 |
Hypertension
Stage 1 Stage 2 Stage 3 |
140–159 160–179 ³ 180 |
or
or or |
90–99 100–109 ³ 110 |
* Untuk dewasa berusia 18 atau lebih yang tidak dalam pengobatan anti hipertensi dan tidak dalam kondisi akut. Ketika tekanan sistole dan diastole masuk ke dalam kategori lain, maka kategori di atasnya harus dipilih untuk menentukan klasifikasi status tekanan darah penderita. Sebagai tambahan dalam menentukan stadium hipertensi, seorang praktisi medis harus menentukan ada atau tidaknya penyakit pada target organ serta faktor resiko lainnya.
1 Tekanan darah yang optimal terhadap resiko kardiovaskular adalah dibawah 120/88 m Hg. Namun demikian, nilai rendah yang tidak wajar harus dievaluasi untuk menemukan kelainan klinis yang signifikan.
2 Berdasarkan atas pembacaan sebanyak 2 kali atau lebih pada pemeriksaan awal.